Tag: Covid19 Vaccine

COVID19 Vaccine Shots Can Be Taken During Ramzan, Say Islamic Scholars
COVID19 Vaccine Shots Can Be Taken During Ramzan, Say Islamic Scholars

Srinagar/Lucknow: Taking the COVID-19 vaccine does not invalidate the Ramzan fast, Muslim scholars said on Tuesday, appealing to people not to stop taking the shots during the ‘roza’ period. A…

  • Tuesday, 13 April 2021
COVID19-Vaccine-Russia
COVID-19 Vaccine: Russia's Top Doctor Quits Over Vaccine Registration

Moscow: A top respiratory doctor quit the Russian health ministry’s ethics council after the country decided to go ahead with the registration of a Covid-19 vaccine even before conducting a crucial Phase 3 trial, MailOnline reported. It appears that Professor Alexander Chuchalin wanted to block the registration of the vaccine on “safety” grounds, before quitting […]

  • Tuesday, 13 April 2021
COVID19-Vaccine-Human-Trial
COVID-19 Vaccine Candidate To Enter 3rd Phase Human Trial, Informs Health Ministry

New Delhi: The Ministry of Health and Family Welfare informed on Tuesday that one of the three COVID-19 vaccine candidates would enter the third phase of the pre-clinical human trial by Wednesday. Dr V.K. Paul, head of the national task force on COVID-19 informed about the development during a weekly press briefing. The ministry officials […]

  • Tuesday, 13 April 2021
Anti-Fibrotic Drugs
COVID-19: Anti-Fibrotic Drugs Effective On Patients, Says Army

Mumbai: For the first time in the country, anti-fibrotic drugs have been used to treat patients suffering from COVID-19-related lung fibrosis and breathlessness which has helped in the recovery of four such patients in Maharashtra’s Pune, the Army has said. “The researchers at the Pune-based Army Institute of Cardiothoracic Sciences (AICTS) have found this therapy […]

  • Tuesday, 13 April 2021
COVID-19 Vaccine: Stage Set For Phase II Clinical Trials Of Bharat Biotech's Vax
COVID-19 Vaccine: Stage Set For Phase II Clinical Trials Of Bharat Biotech's Vax

Hyderabad: The stage is set for phase II clinical trials of Bharat Biotech’s coronavirus vaccine from Monday. The Hyderabad-based vaccine maker received the approval from Central Drugs Standard Control Organisation under the Directorate General of Health Services to conduct the phase II trials of indigenous vaccine candidate Covaxin. Joint Drugs Controller Dr S. Eswara Reddy […]

  • Monday, 12 April 2021
Amazon India To Cover Covid-19 Vaccine Cost For 10 Lakh People
Amazon India To Cover Covid-19 Vaccine Cost For 10 Lakh People

New Delhi: As individuals above 45 years of age in the country can now get Covid-19 vaccines, Amazon India on Monday said that it will cover the cost of Covid-19…

  • Monday, 12 April 2021
Aerum-Institute
Serum Institute To Manufacture 200mn Doses Of COVID19 Vaccine

New Delhi: A further collaboration among the Serum Institute of India (SII), the world’s largest vaccine manufacturer by volume, Gavi and the Bill and Melinda Gates Foundation will accelerate the manufacture and delivery of up to 100 million doses of safe and effective Covid-19 vaccines for India and low-and middle income countries. This brings the […]

  • Monday, 12 April 2021
Bharat Biotech: No Major Adverse Events In 2 Phases Of Covaxin Trials
Bharat Biotech: No Major Adverse Events In 2 Phases Of Covaxin Trials

Hyderabad: Bharat Biotech, which recently received approval to conduct Phase III human trials of India’s first indigenous coronavirus vaccine, Covaxin, has said that the vaccine has been found to be safe without any major adverse events in the first two stages of trials and that its goal is to attain strong immune response rate in […]

  • Saturday, 10 April 2021
Serum Institute Aims To Have 100m Doses Of AstraZeneca Vaccine Ready By Dec
Serum Institute Aims To Have 100m Doses Of AstraZeneca Vaccine Ready By Dec

New Delhi: Serum Institute of India (SII) is ramping up production of AstraZeneca’s Covid-19 vaccine, aiming to have 100 million doses ready by December for a vaccination drive that could begin across India that same month, Bloomberg reported. If final-stage trial data show that AstraZeneca’s vaccine candidate is giving effective protection from the virus, SII […]

  • Friday, 09 April 2021
Covaxin's Phase-3 Trials Begin: Bharat Biotech
Covaxin's Phase-3 Trials Begin: Bharat Biotech

Hyderabad: Phase-3 trials of Covaxin, India’s first indigenous vaccine for Covid-19 commenced today, vaccine maker Bharat Biotech announced on Monday. The Phase-3 trials, which involve 26,000 volunteers across India, are being conducted in partnership with the Indian Council of Medical Research (ICMR). This is India’s first Phase-3 efficacy study for a Covid-19 vaccine, and the […]

  • Friday, 09 April 2021
Odisha: Phase-3 Human Trials Of Covaxin Begins At SUM Hospital
Odisha: Phase-3 Human Trials Of Covaxin Begins At SUM Hospital

Bhubaneswar: The third phase human trial of Covid-19 vaccine candidate ‘Covaxin’ began at the Institute of Medical Sciences and SUM Hospital in Bhubaneswar on Friday. This is the only institute in the State chosen by the Indian Council for Medical Research (ICMR) for the human trial of the vaccine. The vaccine was administered to two […]

  • Friday, 09 April 2021
Moderna COVID-19 Vaccine: Govts May Have To Shell Out $25-$37 Per Dose
Moderna COVID-19 Vaccine: Govts May Have To Shell Out $25-$37 Per Dose

Berlin: Governments seeking to purchase Moderna’s potential Covid-19 vaccine may have to shell out $25 and $37 per dose, depending on the size of the order, the company’s CEO Stephane Bancel told German weekly ‘Welt am Sonntag’ (WamS). Bancel said that the price he quoted was a “fair price” and that the company was not […]

  • Friday, 09 April 2021
AstraZeneca Admits Dosing Error In COVID Vax, Faces Tough Questions From Experts
AstraZeneca Admits Dosing Error In COVID Vax, Faces Tough Questions From Experts

New York: Drugmaker AstraZeneca is now facing tough questions from experts after the company admitted a manufacturing error by a contractor. Earlier this week, the drug manufacturer has announced about the promising results from its Covid-19 vaccine trial After disclosing promising results. AstraZeneca on Monday had announced that it recorded positive high-level results from an […]

  • Friday, 09 April 2021
PM Modi To Review COVID-19 Vaccine Work In Hyderabad, Ahmedabad, Pune
PM Modi To Review COVID-19 Vaccine Work In Hyderabad, Ahmedabad, Pune

Ahmedabad/Pune/Hyderabad: Prime Minister Narendra Modi will visit Hyderabad, Ahmedabad and Pune on Saturday to review coronavirus vaccine development work at facilities there, the Prime Minister’s Office (PMO) said. “Tomorrow, PM @narendramodi will embark on a 3 city visit to personally review the vaccine development & manufacturing process. He will visit the Zydus Biotech Park in […]

  • Friday, 09 April 2021
Adar Poonawalla
Serum Institute To Seek Emergency Use Authorisation For Covishield Vaccine In 2 Weeks: Poonawalla

New Delhi: The Serum Institute of India (SII) will seek emergency use authorisation for the AstraZeneca Covid 19 vaccine in about two weeks. Adar Poonawalla, Founder and CEO, SII said on Saturday that SII is in the process of submitting the data for the clinical trials to the DCGI and will seek emergency use authorisation. […]

  • Friday, 09 April 2021
scrollToTop